These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 30477208)
21. Development of CRISPR-Mediated Systems in the Study of Duchenne Muscular Dystrophy. Cai A; Kong X Hum Gene Ther Methods; 2019 Jun; 30(3):71-80. PubMed ID: 31062609 [TBL] [Abstract][Full Text] [Related]
22. Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy. Amoasii L; Long C; Li H; Mireault AA; Shelton JM; Sanchez-Ortiz E; McAnally JR; Bhattacharyya S; Schmidt F; Grimm D; Hauschka SD; Bassel-Duby R; Olson EN Sci Transl Med; 2017 Nov; 9(418):. PubMed ID: 29187645 [TBL] [Abstract][Full Text] [Related]
24. Single-swap editing for the correction of common Duchenne muscular dystrophy mutations. Chai AC; Chemello F; Li H; Nishiyama T; Chen K; Zhang Y; Sánchez-Ortiz E; Alomar A; Xu L; Liu N; Bassel-Duby R; Olson EN Mol Ther Nucleic Acids; 2023 Jun; 32():522-535. PubMed ID: 37215149 [TBL] [Abstract][Full Text] [Related]
25. Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice. Karri DR; Zhang Y; Chemello F; Min YL; Huang J; Kim J; Mammen PPA; Xu L; Liu N; Bassel-Duby R; Olson EN Mol Ther Nucleic Acids; 2022 Jun; 28():154-167. PubMed ID: 35402069 [TBL] [Abstract][Full Text] [Related]
26. Delivery challenges for CRISPR-Cas9 genome editing for Duchenne muscular dystrophy. Padmaswari MH; Agrawal S; Jia MS; Ivy A; Maxenberger DA; Burcham LA; Nelson CE Biophys Rev (Melville); 2023 Mar; 4(1):011307. PubMed ID: 36864908 [TBL] [Abstract][Full Text] [Related]
27. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9. Sui T; Lau YS; Liu D; Liu T; Xu L; Gao Y; Lai L; Li Z; Han R Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29871865 [TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein. Egorova TV; Polikarpova AV; Vassilieva SG; Dzhenkova MA; Savchenko IM; Velyaev OA; Shmidt AA; Soldatov VO; Pokrovskii MV; Deykin AV; Bardina MV Mol Ther Methods Clin Dev; 2023 Sep; 30():161-180. PubMed ID: 37457303 [TBL] [Abstract][Full Text] [Related]
37. CRISPR applications for Duchenne muscular dystrophy: From animal models to potential therapies. Chey YCJ; Arudkumar J; Aartsma-Rus A; Adikusuma F; Thomas PQ WIREs Mech Dis; 2023 Jan; 15(1):e1580. PubMed ID: 35909075 [TBL] [Abstract][Full Text] [Related]
38. Using CRISPR/Cas9 System to Knock out Exon 48 in Dara M; Razban V; Talebzadeh M; Moradi S; Dianatpour M Avicenna J Med Biotechnol; 2021; 13(2):54-57. PubMed ID: 34012519 [TBL] [Abstract][Full Text] [Related]
39. Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping. Wang P; Li H; Zhu M; Han RY; Guo S; Han R Mol Ther Methods Clin Dev; 2023 Mar; 28():40-50. PubMed ID: 36588820 [TBL] [Abstract][Full Text] [Related]